Amazon Faces Allegations Over Millions in Profits from NowIllegal Pricing Policy
Microsoft and Anthropic in Talks for Custom AI Chip Supply After 5 Billion Investment
US Official Highlights Japans Role in Fentanyl Smuggling Route Raising Trade Security Concerns
SEBI Chief Tuhin Kanta Pandey Highlights Indias Diversified Market Amid Taiwans Ascent on TSMC and AI Boom
Market Digest Allstate Electronic Arts Packaging Corp of America Sector Moves in Focus
India and South Korea Aim to Address Widening Trade Deficit in CEPA Renegotiation Talks
ESS Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency
PAM Q1 2026 Earnings Staggering EPS Beat as Operating Performance Surges
CRK Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges
HAYW Q1 2026 Earnings EPS Surpasses Estimates by 1414 as Stock Declines Slightly
ARM Q1 2026 Earnings EPS Beat Amidst Revenue Discrepancy Uncertainty
BRC Group Holdings Inc 550 Senior Notes Due 2026 RILYK Q1 2024 Earnings Negative EPS Highlights Operational Strain as Bond Price Edges Higher
Colony Bankcorp CBAN Edges Lower as Shares Approach Key Support Level
ArrowMark Financial Corp BANX Holds Near Support as Slight Downtick Persists
GRAIL Inc GRAL Advances Over 35 as Momentum Tests Key Resistance Zone
Ames National Corporation ATLO Edges Lower as Price Action Remains RangeBound
ARKO Petroleum Corp APC Stock Slips Nearly 2 as Shares Approach Key Support
Czech Scientists Develop ClimateResilient Hops to Protect Signature Beer Flavor
UK Exports to US Tumble 25 as Trump Tariffs Reshape Trade Dynamics
Firefly FLY Stock Surges 15 on Rosy Space Sector Outlook
Traders on Prediction Markets See Rising Odds of Fed Rate Hike by July 2027
Vanguard Dividend Appreciation ETF vs Fidelity High Dividend ETF Weighing Yield Fees and Performance
Government Plans Up to 2 Stake Sale in LIC Potentially Raising Rs 10000 Crore
IBMs Quantum Leap 27 Billion Market Cap Surge After Federal Quantum Computing Investment
OGEN Q2 2023 Earnings EPS Surprise Beats Estimates Amid No Revenue Cash Burn Concerns
Akebia Therapeutics AKBA Edges Higher Testing Key Resistance Near 111